Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.0 - $23.99 $0 - $167,210
-6,970 Reduced 83.57%
1,370 $0
Q3 2023

Nov 14, 2023

BUY
$21.54 - $24.41 $66,515 - $75,378
3,088 Added 58.8%
8,340 $188,000
Q2 2023

Aug 14, 2023

BUY
$12.62 - $24.47 $9,906 - $19,208
785 Added 17.57%
5,252 $128,000
Q1 2023

May 12, 2023

BUY
$12.98 - $17.1 $57,981 - $76,385
4,467 New
4,467 $60,000
Q2 2022

Aug 15, 2022

SELL
$12.69 - $19.25 $2,258 - $3,426
-178 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$15.5 - $23.89 $232 - $358
15 Added 9.2%
178 $3,000
Q4 2021

Feb 11, 2022

BUY
$20.04 - $23.84 $3,266 - $3,885
163 New
163 $4,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.